Becton Dickinson Total Assets 2010-2022 | BDX

Becton Dickinson total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Becton Dickinson total assets for the quarter ending March 31, 2022 were $54.786B, a 0.25% decline year-over-year.
  • Becton Dickinson total assets for 2021 were $53.866B, a 0.27% decline from 2020.
  • Becton Dickinson total assets for 2020 were $54.012B, a 4.34% increase from 2019.
  • Becton Dickinson total assets for 2019 were $51.765B, a 3.97% decline from 2018.
Becton Dickinson Annual Total Assets
(Millions of US $)
2021 $53,866
2020 $54,012
2019 $51,765
2018 $53,904
2017 $37,734
2016 $25,586
2015 $26,478
2014 $12,447
2013 $12,149
2012 $11,361
2011 $10,430
2010 $9,651
2009 $9,305
Becton Dickinson Quarterly Total Assets
(Millions of US $)
2022-03-31 $54,786
2021-12-31 $53,363
2021-09-30 $53,866
2021-06-30 $54,333
2021-03-31 $54,921
2020-12-31 $54,748
2020-09-30 $54,012
2020-06-30 $53,959
2020-03-31 $53,516
2019-12-31 $51,952
2019-09-30 $51,765
2019-06-30 $52,233
2019-03-31 $52,598
2018-12-31 $52,932
2018-09-30 $53,904
2018-06-30 $53,977
2018-03-31 $54,573
2017-12-31 $55,363
2017-09-30 $37,734
2017-06-30 $37,166
2017-03-31 $24,121
2016-12-31 $24,318
2016-09-30 $25,586
2016-06-30 $26,016
2016-03-31 $26,236
2015-12-31 $26,046
2015-09-30 $26,478
2015-06-30 $27,079
2015-03-31 $28,293
2014-12-31 $18,503
2014-09-30 $12,447
2014-06-30 $12,374
2014-03-31 $12,250
2013-12-31 $12,035
2013-09-30 $12,149
2013-06-30 $11,587
2013-03-31 $11,630
2012-12-31 $11,629
2012-09-30 $11,361
2012-06-30 $11,025
2012-03-31 $11,195
2011-12-31 $11,413
2011-09-30 $10,430
2011-06-30 $10,621
2011-03-31 $10,344
2010-12-31 $10,071
2010-09-30 $9,651
2010-06-30 $9,032
2010-03-31 $8,943
2009-12-31 $9,094
2009-09-30 $9,305
2009-06-30 $8,849
2009-03-31 $7,576
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $71.295B $20.248B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $46.842B 13.77
AmerisourceBergen (ABC) United States $31.256B 14.42
West Pharmaceutical Services (WST) United States $22.580B 34.40
Laboratory Of America Holdings (LH) United States $22.369B 9.34
Cooper (COO) United States $15.890B 24.45
Cardinal Health (CAH) United States $14.945B 11.48
CONMED (CNMD) United States $2.875B 29.69
Invacare (IVC) United States $0.055B 0.00